The chemokine receptor CCR7 is a central regulator in the maintenance of cellular homeostasis of mucosal tissues. CCR7−/− mice develop autoimmune gastritis and exocrinopathy accompanied by the formation of mucosal tertiary lymphoid follicles. Here we found that CCR7-deficient mice frequently suffered from chronic diarrhea linked with increased gastrointestinal motility and the development of severe anorectal prolapse. Enhanced formation of intestinal lymphoid follicles was associated with an elevated proportion of activated colonic T cells and increased production of the cytokine interleukin (IL)-1β. To uncover the pathomechanisms of diarrhea in CCR7−/− mice, colonic epithelial barrier and ion channel activities were analyzed in Ussing chambers. Although overt acute colitis was absent, CCR7 deficiency resulted in reduced electrogenic sodium absorption and colonic chloride secretion. As it is known that IL-1β regulates epithelial sodium channel (ENaC) activity, these data imply a causal link between CCR7 expression, IL-1β level, and Na+ malabsorption owing to altered ENaC expression and diarrhea.
The mucosal surfaces of the gastrointestinal (GI) tract represent one of the largest lymphoid compartments in the body. Although the mucosal immune system is essential for protecting the host against infectious and toxic assaults, it must simultaneously ignore commensal organisms and dietary antigens. Uncontrolled immune reactions against commensal bacteria, innocuous antigens, or host epithelial cells can lead to autoimmune disease such as chronic inflammatory bowel disease.1, 2, 3, 4
The inductive compartment—presumed to sample antigens from mucosal surfaces to stimulate cognate naive T and B lymphocytes—includes the organized mucosa-associated lymphoid tissue, whereas the effector compartment consists of the lamina propria, the stroma of exocrine glands, and the intestinal epithelial lining.5 However, the interplay between lymphoid follicles as a hallmark structure of the mucosa-associated lymphoid tissue and the intestinal epithelia as one of the major effector sites is not well understood.
The CCR7 knockout (CCR7−/−) mice are a well-characterized model to study the function of tertiary lymphoid follicles (TLFs) in cellular mucosal homeostasis, as loss of CCR7 induces formation of tertiary lymphoid follicles throughout the GI mucosa. CCR7, which is known to be a major lymph-node homing receptor for lymphocytes and dendritic cells, facilitates the induction of adaptive immune responses as well as homeostatic lymphocytic recirculation.6, 7, 8 Dysregulation of immune homeostasis and adaptive immunity in CCR7−/− mice is associated with induction of autoimmunity,9 especially autoimmune gastritis (AIG).10
In the present study, we demonstrate that lack of CCR7 is also associated with chronic diarrhea, suggesting a dysregulation of intestinal mucosal homeostasis. Most often, diarrhea secondary to an activation of the mucosal immune system goes along with a breakdown of the epithelial barrier leading to leak-flux diarrhea.11 However, other etiologies for diarrhea, e.g., specific bacterial toxins, endocrinopathies, conditions of malassimilation, neuropathies, and neoplastic diseases, induce secretory or osmotic pathomechanisms that are not primarily associated with epithelial cell death.12, 13
This work presents evidence for an immune-mediated condition (i.e., tertiary lymphoid follicle formation in CCR7−/− mice) causing a dosed immune response of pro-inflammatory cytokines, resulting in the modulation of ion channel activities on enterocytes and in a Na+-malabsorptive type rather than a leak-flux type of diarrhea.
CCR7−/− mice frequently develop an anorectal prolapse and exhibit reduced whole-gut transit time but no differences in epithelial resistance
CCR7−/− mice frequently suffered from nonbloody, chronic diarrhea, which was emphasized by the fact that 34% of the CCR7−/− animals (n=50) developed a severe anorectal prolapse within 2–12 months of age (as compared with only a single Wt mouse out of 35 animals (2.9%)) (Figure 1a). Secondly, the whole-gut transit time reflecting GI motility was significantly reduced in CCR7−/− mice when compared with Wt mice (Figure 1b).
It was shown earlier that CCR7−/− mice develop moderate multi-organ autoimmunity accompanied by the formation of lymphoid aggregates at mucosal sites.9, 14 Recently, we characterized an inflammatory milieu in the gastric mucosal tissue of CCR7−/− mice that supported the development of autoimmune gastritis in these animals.10 Secretion of mucosal inflammatory cytokines has also been linked to an altered epithelial barrier function.15, 16 Hence, we aimed to resolve an association of the observed clinical features with possible changes in epithelial barrier function. To differentiate the contribution of the epithelial and subepithelial mucosal compartment to barrier function, alternating current impedance spectroscopy was performed on colonic specimens obtained from 8–12-week-old Wt and CCR7−/− mice. However, the epithelial resistance (Re) of CCR7−/− mice was not significantly different compared with Wt littermates (Figure 1c). In contrast to Re, the subepithelial resistance (Rs) was found to be significantly (1.4-fold) higher in CCR7−/− mice, accounting for a higher transmural resistance (Rt). Most likely, this is explained by the increased cellularity present in the subepithelial tissue of CCR7−/− compared with Wt mice (Figure 1d,e). Importantly, the mucosal surface area, determined by crypt width, length, and number, was not significantly different in Wt and CCR7−/− mice (data not shown).
Accelerated formation of isolated lymphoid follicles (ILFs) in the large intestine of CCR7-deficient mice
We previously reported that the mucosal tissue of CCR7−/− mice is highly permissive for the formation of lymphoid aggregates, which develop into ectopic follicular structures particularly in the stomach and lung.14 Here we further characterized an accelerated development of ILFs in the large intestine of CCR7−/− mice. Histological analysis of 8–12-week-old mice revealed that all CCR7−/− mice developed ILFs that were increased in size and number (Figure 1d,e). For the most part, the cellular composition of CCR7−/− ILFs was comparable to that found in the smaller and less frequently observed ILFs of Wt mice. Thus, all ILFs were rich in B cells, whereas T cells were scattered not only within these lymphoid structures, but also throughout the whole lamina propria (LP) of the colon (Figure 2a). Small clusters of macrophages and single neutrophils adjacent to ILFs were observed in CCR7−/− mice and, in some cases, also in Wt controls (Supplementary Figure S1 online). However, no active neutrophil-dominated inflammation was present in CCR7−/− or Wt mice. Mast cells that can also potentially contribute to an acute inflammatory colitis17, 18, 19, 20, 21 have not been detected in the colonic LP of CCR7−/− or Wt mice (Supplementary Figure S2 online).
The number of CD3+ T cells within the LP, aside of the ILFs, was also increased in CCR7−/− compared with Wt mice (Figure 2b). Additionally, enhanced numbers of apoptotic activated caspase3-positive cells were found in the LP of CCR7−/− compared with Wt mice (Figure 2c), suggesting an enhanced cellular turnover in CCR7−/− mice. The amount of epithelial periodic acid-Schiff-positive goblet cells was mildly decreased (Figure 2d), probably owing to some displacement of goblet cells by expansion of ILFs in CCR7−/− mice. By contrast, the number of intraepithelial CD3+ T cells or activated caspase3-positive lymphocytes was comparable in Wt and CCR7−/− mice (Figure 2e,f), underlining that increased lymphoid cellularity was limited to the LP and submucosa, and did not occur intraepithelially.
CCR7−/− mice exhibit increased serum immunoglobulin (Ig)G and IgM titers against colonic antigen and contain increased numbers of Foxp3+ regulatory T cells (Tregs) within ILFs compared with Wt mice
CCR7-deficient mice frequently displayed large ILFs with surprisingly high numbers of Foxp3+ Tregs within and adjacent to these lymphoid structures (Figure 3a). By contrast, ILFs of Wt mice contained only single Foxp3+ Tregs (Figure 3a). We quantified the total amount of Tregs within the LP of the large intestine in 12-week-old animals. Flow cytometry analysis revealed strongly increased numbers of LP Foxp3+ Tregs in CCR7−/− (>10-fold) compared with Wt mice (Figure 3b). Additionally, we determined serum titers of autoantibodies directed against colonic antigen. Colonic antigen-specific IgG and IgM titers were significantly increased in CCR7−/− compared with Wt mice (Figure 3c,d). Serum-derived anti-colonic IgM antibodies of CCR7−/− mice were specifically directed to colonic enterocytes (Figure 3d; right panel), indicating a humoral autoimmune response against the intestinal epithelial layers in CCR7-deficient mice.
Expression of activation markers on intestinal T cells and colonic production of interleukin (IL)-1β are increased in CCR7−/− mice
T-cell activation is associated with high expression of CD69 and CD44 and low expression of CD62L. We analyzed the activation status of CCR7-deficient colon-resident lymphocytes in comparison with Wt lymphocytes by flow cytometry. The early activation antigen CD69 was expressed on 48.6±3.2% (n=4) of colonic mucosa-derived CD4+ and 92.3±1.1% (n=4) of CD8+ CCR7−/− T lymphocytes compared with 35.2±1.1% (n=4) of colonic-derived CD4+ and 81.7±6.2% (n=4) of CD8+ Wt T lymphocytes (Figure 4a). The percentage of CD69+ CD4+ and CD8+ T cells that co-expressed a second activation marker, CD44, was also increased in the CCR7−/− compared with Wt mice (Figure 4b), but the difference was not statistically significant. However, the increase in the numbers of total activated CD4+ and CD8+ T cells in CCR7−/− mice was more profound than the relative (percentage) increase of activated T cells, as CCR7-deficient mice have more CD3+ T cells in the LP (Figure 2b).
Whole-organ cultures of the transverse and distal parts of the colon were assayed for the secretion of the inflammatory T helper (Th)1-type associated cytokines interferon-γ (IFN-γ), IL-6, tumor-necrosis factor (TNF)-α, IL-1β, and IL-15, and for the Th2-type-associated cytokines IL-4 and IL-13. CCR7−/− mice revealed a significant increase in colonic IL-1β production (Figure 4c). We identified CD11c+ dendritic cells within the colonic lymphoid aggregates as the major cellular source of IL-1β production (Figure 4d) and their total numbers were substantially increased in CCR7−/− mice (Figure 4d). Th17 effector T-cell responses (marked by IL-17 production) were also elevated; however, statistical significance was not reached (Supplementary Figure S3c online). No substantial differences were observed for colonic protein levels of IL-6, TNF-α, and IFN-γ (Supplementary Figure S3a, b, and d online) and the Th2 cytokines IL-4 and IL-13 were at the detection limit in both Wt and CCR7−/− mice (data not shown). Colonic IL-15 levels, a cytokine that exerts a complex function by mediating deleterious as well as protective effects on intestinal epithelia,22, 23 were substantially decreased in CCR7−/− compared with Wt mice (Figure 4e). Taken together, colon-infiltrating lymphocytes and dendritic cells support a chronic inflammatory intestinal milieu in CCR7-deficient mice.
CCR7−/− mice exhibit downregulated colonic chloride secretion and decreased cystic fibrosis transmembrane conductance regulator (CFTR) mRNA levels compared with Wt mice
It has been described that inflammatory stimuli, i.e., IL-1β, TNF-α, and IFN-γ, can affect intestinal barrier function15, 16 and also can change the balance between fluid absorption and secretion of the intestinal epithelium.24, 25 Here we analyzed electrogenic chloride secretion in the Ussing chamber across isolated mucosa of distal colon segments taken from 10–12-week-old Wt and CCR7−/− mice. CCR7-deficient mice displayed reduced chloride secretion compared with Wt animals (Figure 5a). Because colonocytes exert apical chloride secretion mostly via the CFTR,26 we quantified the expression level of CFTR mRNA in distal colon segments of 4- and 8-week-old Wt and CCR7−/− mice by quantitative real-time PCR analysis. In line with the downregulation of Cl− secretion in CCR7−/− mice, we observed reduced CFTR mRNA levels in colonic tissues of CCR7−/− compared with Wt mice (Figure 5b). As CCR7−/− mice showed a normal mucosal surface area, downregulation of Cl− secretion is not merely linked to a reduced number of epithelial cells. Hence, we suggest that the impaired chloride secretion is associated with reduced CFTR expression.
CCR7−/− mice displayed reduced electrogenic sodium transport after aldosterone induction and decreased α-, β-, and γ-epithelial sodium channel (ENaC) subunit mRNA levels
The rate-limiting factor for sodium absorption along the large intestine is the amiloride-sensitive ENaC. First, we measured ENaC activity by determining aldosterone-induced, amiloride-sensitive short circuit current (Isc), expressed as monovalent cation flux (JNa). In Wt colon mucosa, aldosterone induced a strong increase in Isc, which dropped again after administration of amiloride (Figure 6a, left panel). By contrast, CCR7−/− colon mucosa showed a much lower increase in Isc after aldosterone treatment and accordingly the amiloride-sensitive drop was also smaller in comparison with Wt mice (Figure 6a, left panel). Next, we analyzed whether colonic ENaC mRNA expression was altered in CCR7−/− mice. Colonic ENaC mRNA expression of the α- and β-ENaC subunit was significantly reduced in CCR7−/− mice compared with Wt controls (Figure 6b). Overall, electrogenic sodium transport as well as α-, β-, and γ-ENaC subunit mRNA expression levels were lower in colon specimens of CCR7−/− mice. Given the increased IL-1β expression in CCR7−/− mice, we next analyzed the capacity of IL-1β to reduce ENaC function. Rat late distal colon was mounted in Ussing chambers and ENaC activity was measured after induction with aldosterone of the mucosae in the presence of IL-1β (Figure 7a,b). As previously published, IL-1β significantly reduced ENaC-associated cation flux by 72%.24 We further evaluated the signal transduction pathway that—when activated by IL-1β—induces the downregulation of ENaC. Since we and the others have previously implicated extracellular signal–regulated kinase (ERK) and p38 signaling to be involved in ENaC regulation, rat colon mucosae were preincubated with specific inhibitors (U0126, 10 μM for ERK and SB202190, 10 μM for p38).27, 28 Both inhibitors reversed the IL-1β-induced reduction of ENaC current, although they had—when applied in the absence of IL-1β—no effect on ENaC activity.
In a recent study, we demonstrated that mice that lack CCR7 develop an early spontaneous autoimmune gastritis.10 This was associated with the formation of lymphoid aggregates at mucosal GI sites including the stomach, colon, and lung.9, 14
In the present study, we show that CCR7−/− mice suffer from chronic diarrhea leading to frequent anal prolaps and to a reduced whole-gut transit time. Interestingly, chronic diarrhea in CCR7−/− mice was present in the absence of overt colitis. CCR7−/− mice exhibited increased colonic lymphoid cellularity with enlarged isolated ILFs. These aggregates consisted mainly of B and T lymphocytes and small clusters of macrophages. This is contrary to transgenic mouse models, i.e., IL-2−/− mice, which develop diarrhea owing to an acute intestinal inflammation with infiltration of the gut mucosa by lymphocytes, plasma cells, and granulocytes, expression of a variety of pro-inflammatory cytokines, as well as ulcerations and crypt abscesses.29 Consistent with the lack of an acute mucosal inflammation, the pro-inflammatory cytokines IL-6, TNF-α, and IFN-γ, frequently associated with colitis induction,30, 31 were not found to be elevated in CCR7−/− colon mucosa. Moreover, no experimental evidence was found that mast cells or mast-cell-derived cytokines, which have been associated with acute inflammation in inflammatory bowel disease,20, 32 contributed to chronic diarrhea in CCR7−/− mice.
By contrast, secretion of the pro-inflammatory cytokine IL-1β was significantly increased in CCR7−/− mice. This is in agreement with our recent finding that local gastric IL-1β expression is enhanced in naive CCR7−/− mice, whereas other pro-inflammatory cytokines are unaltered.10 Previous studies regarding the effect of T cell–induced colonic inflammation on bowel dysfunction indicated that activated intestinal T cells can damage the epithelial barrier through cytokine-mediated pathways even before histological signs of acute inflammation emerge.33, 34
IL-15, a cytokine that is constitutively expressed by a variety of cell types, including macrophages and intestinal epithelial cells,35 was found to be decreased in the CCR7−/− colon mucosa. Previous work on IL-15 points to a complex role of this cytokine in epithelial cell function. On the one hand, IL-15 appears to have a deleterious effect on epithelia in T cell–mediated small intestinal diseases like celiac sprue, where it sensitizes epithelia to natural killer cell receptor–mediated cell death by epithelial overexpression of the atypical major histocompatibility complex molecule class 1 related chain A.22, 23 However, another report showed endogenous IL-15 to protect colonocytes from apoptosis in chronic colitis.36 Hence, in certain clinical situations a reduction in local IL-15 expression might even add to the pathology.
Intestinal homeostasis and regulation of intestinal inflammatory responses have been associated with regulator Treg–mediated control mechanisms.37, 38, 39 Here we detected numerous Tregs within the colonic ILFs of CCR7−/− mice and an overall increase in the total colonic Treg cell numbers compared with Wt controls. This is again consistent with what we found in the gastric mucosal tissue of CCR7−/− mice and most likely reflects the inability of CCR7-deficient Tregs to recirculate properly through tissue-associated lymph nodes.10 Hence, Tregs are present in large numbers but do not efficiently support maintenance of GI homeostasis.
What additional mechanism other than an acute inflammation might contribute to diarrhea in CCR7−/− mice? Data presented herein suggest that the downregulation of the sodium-absorbing ENaC has a prominent role. ENaC is expressed at the apical epithelial cell membrane, causing water resorption secondary to absorption of luminal sodium.40 ENaC expression and function are known to be reduced in patients with ulcerative colitis (UC),41 an inflammatory bowel disease leading to severe chronic diarrhea. As IL-1β was the only pro-inflammatory cytokine found to be profoundly elevated in CCR7−/− mice, it is of special interest that IL-1β preincubation of healthy murine colon mucosa is already known to reduce ENaC activity.24 Similar to what we found in CCR7−/− mice, this is elicited by the downregulation of ENaC mRNA.24 The importance of ENaC activity in concentrating stool was recently highlighted by the work of Bergann et al.42 that uncovered the mechanisms for the induction of ENaC activity as a driving force for the rapid anti-diarrheal response after corticosteroid treatment in patients with acute exacerbations of inflammatory bowel disease.
To unravel the signaling pathway underlying the downregulation of ENaC activity after IL-1β stimulation, specific inhibitors for ERK and p38 kinase signaling pathways were employed. ERK signaling has previously been identified as a mediator of IL-1β-related ENaC depression in middle-ear epithelial cells, whereas p38 has been suggested as being central to ENaC regulation in alveolar epithelial cells.28, 43 Our results revealed a role for both ERK and p38 kinase in ENaC regulation. These data also showed a partial overlap with a study by Zeissig et al.27 on TNF-α–induced downregulation of ENaC in intestinal epithelial cells, as this pathway was also dependent on ERK signaling.
At first sight, the finding that electrogenic chloride secretion and CFTR activity are reduced in CCR7−/− mice appears to be in contradiction to the fact that these mice suffer from diarrhea. However, similar results were previously presented for ulcerative colitis in human samples, where ENaC downregulation is found in parallel with reduced CFTR activity.15, 41 Furthermore, basal (i.e., unstimulated) Isc values, most likely reflecting chloride secretion, were also shown to be diminished.41 Therefore the pathophysiology of these forms of diarrhea appears not to be associated with an increased chloride secretion, but rather with a reduction in sodium absorption.
In vitro studies by Cafferata et al.44 presented an interesting dual role of IL-1β in the induction of CFTR expression. They found an increased CFTR mRNA and protein expression when T84 cells were treated with low amounts of IL-1β, but downmodulation of CFTR by IL-1β treatment at high doses.
In line with the data of our study, increased IL-1α and IL-1β levels have also been found in the non-inflamed mucosa of Crohn's disease patients.45 The authors showed that colonic IL-1α and IL-1β are increased not only in the inflamed mucosa but also in the non-inflamed mucosa, suggesting continuous activation of the intestinal immune system.45 CCR7−/− mice, as mentioned earlier, revealed increased GI IL-1β secretion without evidence of an acute neutrophil-dominated mucosal inflammation. Furthermore, a continuous activation of the intestinal immune system in CCR7−/− mice was indicated by an increased proportion of activated CD69+CD44+CD4+ and CD69+CD44+CD8+ LP T lymphocytes.
Another human disease where elevated IL-1β levels are associated with a watery diarrhea is familial Mediterranean fever, a periodic fever syndrome. In familial Mediterranean fever, a mutation in the MEFV (Mediterranean fever) gene encoding the protein pyrin causes dysfunction of the inflammasome. This results in elevated IL-1β levels elicited by a complex dysregulation of the inflammasome in monocytes.46 Notably, familial Mediterranean fever patients frequently suffer from diarrhea without showing manifestation of colitis,47 suggesting that modulation of ion channel activity via IL-1β might also be relevant.
Chronic diarrhea is associated with altered GI motility and gut transit time. GI motility dysfunction has been connected with disturbed GI physiology, including altered epithelial, muscle, intestinal, and enteric neural function.48 Hence, a contribution of neuromuscular dysfunction to the reduced gut transit time could also be inferred in CCR7−/− mice. Two recent studies on burn injury and on small-bowel graft transplantation in rats linked increased intestinal cytokine levels, i.e. IL-1β, with delayed intestinal transit.49, 50 In contrast, for Th17 immune activation it was reported that IL-17 enhances muscle cell contractility in mice.48 In our model it remains elusive if inflammatory cytokines can directly affect gut motility, as in CCR7−/− mice colonic expression of both IL-1β and IL-17 is enhanced.
In conclusion, we have demonstrated that in CCR7-deficient mice activated T cells are capable of modulating the activity of luminal ion channels in colonocytes, which results in the development of diarrhea. This adjusted T-cell response includes crossreactivity to intestinal antigen(s) and results in substantially enhanced IL-1β and IL-17 secretion. As a consequence, expression of ion channels on colonocytes is modulated, leading to a reduced net ion transport and colonic fluid accumulation. As this is found in the absence of acute inflammation, the CCR7−/− model points to an alternative pathophysiological mechanism for diarrhea.
Mice. C57BL/6 mice were obtained from Charles River (Sulzfeld, Germany). CCR7−/− were generated as described6 and backcrossed onto a C57BL/6 background for 12 generations. Animals were housed in a specific pathogen-free facility at the Max-Delbrück-Center for Molecular Medicine, Berlin, Germany. All animal studies were performed according to institutional and Berlin State guidelines (registered under LaGeSo 0184/04 and 0371/05).
Immunohistology and histological evaluation. The following primary antibodies were used: goat anti-mouse CD3 (Santa Cruz, Heidelberg, Germany), polyclonal rabbit anti-human CD3 (Dako, Hamburg, Germany), PE-labelled rat anti-mouse IgM, Alexa Fluor 488-labelled hamster anti-mouse CD11c, and biotinylated rat anti-mouse B220 (BD Biosciences, Heidelberg, Germany), polyclonal rabbit anti-mouse cleaved caspase3 (Cell Signalling, Danvers, MA), biotinylated rat anti-F4/80 and rat anti-mouse B220 (Biolegend, Uithoorn, The Netherlands), polyclonal goat anti-mouse IL-1β (R&D Systems, Wiesbaden, Germany), biotinylated rat anti-mouse Foxp3, and purified rat anti-mouse Ly-6G (eBioscience, Frankfurt, Germany). Secondary antibodies included: goat anti-rat-IgG biotin conjugated and donkey anti-rat-IgG biotin conjugated (Jackson Immuno Research, Hamburg, Germany). Alexa Fluor 568-labelled donkey anti-goat IgG was used as secondary antibody (Molecular Probes, Leiden, The Netherlands) in immunofluorescence stainings. Biotinylated antibodies were detected with peroxidase or alkaline phosphatase-coupled Streptavidin (Jackson Immuno Research).
Tissues were fixed in 4% phosphate-buffered formaldehyde, embedded in paraffin, cut into 5-μm cross sections, deparaffinized, and demasked by heat (citrate buffer, pH 6.0) or trypsinization (F4/80, Ly-6G). Endogenous peroxidase activity was blocked with 3% H2O2 and a biotin-blocking step (Vector Laboratories, Loerrach, Germany) was performed before biotinylated antibodies were applied. Primary antibodies were incubated for 30 min–2 h at room temperature or at 4 °C overnight, followed by an appropriate secondary antibody or/and a streptavidin conjugate (alkaline phosphatase or horseradish peroxidase). Horseradish peroxidase activity was detected using the AEC detection system (Dako). Alkaline phosphatase activity was detected using Fast blue salt (Sigma-Aldrich, Munich, Germany). Periodic acid-Schiff histochemistry was conducted in a Dako Autostainer plus (Dako) according to the manufacturer's instructions.
For frozen sections, tissues were embedded in Tissue Tek OCT compound (Sakura Finetek, Staufen, Germany) and frozen on dry ice. Cryosections were cut to 5–8 μm thickness, air dried, and fixed for 10 min in −20 °C acetone. Cryosections were rehydrated in 50 mM Tris-buffered saline, pH 7.6. All slides were mounted in Mowiol solution (11.7% wt/vol Mowiol, 29.4% wt/vol glycerine, 0.12 M Tris, pH 8.5). Images were acquired with a Zeiss Axiophot fluorescence microscope with an Axiocam HRc camera or with an AxioImager Z1 microscope equipped with a charge-coupled device camera (AxioCam MRm) and further processed using AxioVision 4.5 software (Carl Zeiss, Jena, Germany).
The intraepithelial lymphocytes were quantified in hematoxylin and eosin–stained sections by counting the small and round lymphocytes within the basal portion of the surface epithelium per 100 epithelial cells according to a previously published standard method used in routine pathology.51
Electrophysiological measurements. Experiments were carried out as published previously.24, 52 Mouse or rat distal colon mucosa were mounted into Ussing chambers. The bathing fluid consisted of (mM): Na+, 140.0; Cl−, 123.8; K+, 5.4; Ca2+, 1.2; Mg2+, 1.2; HPO42−, 2.4; H2PO4−, 0.6; HCO3−, 21.0; D(+)-glucose, 10.0; β-OH-butyrate, 0.5; glutamine, 2.5; and D(+)-mannose, 10.0. The solution was equilibrated with 95% O2 and 5% CO2 at pH 7.4. Temperature was kept constantly at 37 °C. To avoid bacterial growth, piperacillin (50 mg l−1) and imipenem (10 mg l−1) were added in experiments. Dimethyl sulfoxide and ethanol were used for solubilization of aldosterone and did not affect short-circuit current or transepithelial resistance at the concentrations used in the experiments. Piperacillin, imipenem, and dimethyl sulfoxide itself had no effect on transport and barrier parameters. The exposed tissue area was 0.049 cm2 for mouse colon and 0.54 cm2 for rat colon Ussing experiments. Voltage (mV) and tissue resistance ( cm2) were constantly recorded and used to calculate equivalent short-circuit current (Isc) by Ohm's law (I=U/R) using a six- or eight-channel computer-controlled voltage clamp device (CVC-6 or CVC-8, Fiebig, Berlin, Germany). In Ussing experiments using rat late distal colon for elucidation of IL-1β-mediated signaling, inhibitors of mitogen-activated protein kinase/ERK kinase 1/2 (U0126, Cell Signaling Technology, Frankfurt am Main, Germany) and p38 mitogen-activated protein kinase (SB202190, Calbiochem, Darmstadt, Germany) were added (10 μM) for 1 h followed by addition of rat IL-1β (IL-1β, final concentration: 10 ng ml−1, 10 U ng−1, Biotrend, Germany) for 6 h and aldosterone (3 × 10−9 M, Sigma, Schnelldorf, Germany) for further 8 h. The drop in Isc after addition of amiloride (10−4 M, Sigma, Schnelldorf, Germany) was assigned to ENaC-dependent sodium flux and is expressed as the flux of monovalent cations (μmol h−1 cm−2). For measuring electrogenic Cl− secretion in mouse colon, tissues were stimulated by prostaglandin E2 (2.8 nmol l−1, serosal side) and theophylline (10 mmol l−1, both sides). The increase in Isc (ΔIsc) was measured thereafter.
Transmural impedance analysis. Transmural alternating current impedance spectroscopy was performed as described earlier.53 Briefly, mouse colon was mounted into a miniaturized Ussing chamber as described above and 48 discrete frequencies of an effective sine-wave alternating current of 35 μA·cm−2 were applied ranging from 1.3 Hz to 65 kHz. Resulting changes in tissue voltage were detected by phase-sensitive amplifiers. Calculated complex impedance values were plotted in a Nyquist diagram and fitted by least-square analysis. Rt (transepithelial resistance) was obtained at low and Rs (subepithelial resistance) at high frequencies. Re=Rt−Rs, where Re indicates epithelial resistance.
Whole-gut transit time. After a 24-h fast with access to water, 0.3 ml of glutinous liquid, consisting of Karmin Red and 1.5% methyl cellulose (both Sigma-Aldrich), was administered by gastric gavage. The time from administration to evacuation of dyed feces was measured.
Isolation of lamina propria leukocytes from colonic tissue. Minced tissue of murine colons was shaken in Hank's balanced salt solution (w/o Mg/Ca) supplemented with 5 mM ethylenediaminetetraacetic acid and 1 mM dithiothreitol for 30 min at 37 °C. Tissue debris were washed twice with RPMI 1640 medium and further digested in RPMI 1640 medium supplemented with 10% fetal calf serum, 2 mM glutamine, 50 μM β-mercaptoethanol, 0.5 mg ml−1 Collagenase D (Roche), and 20 μg ml−1 DNAse I for 90 min at 37 °C under agitation. Single-cell suspensions were obtained by passing the enzymatic digest through a nylon mesh, followed by a Percoll density gradient centrifugation.
Flow cytometry analysis. The following primary antibodies were used: fluorescein isothiocyanate-conjugated rat anti-mouse CD69; phycoerythrin-conjugated rat anti-mouse CD44 and CD45; and allophycocyanin-conjugated rat anti-mouse CD4, CD8, and CD117 (c-kit) (all from Biolegend, Uithoorn, The Netherlands). Data were acquired on a FACS Calibur flow cytometer (BD Biosciences) and analyzed with Flowjo software version 8.8.2 (BD Biosciences).
RNA isolation, reverse transcription, and quantitative real-time PCR. Total RNA from murine colons was extracted using the RNeasy Midi Kit (Qiagen, Hilden, Germany), and RNA integrity was confirmed with an Agilent (Böblingen, Germany) Bioanalyzer system. cDNA synthesis was performed with oligo(dT) primers using the SuperScript III First-Strand Synthesis Kit (Invitrogen, Darmstadt, Germany). Reverse transcription and quantitative real-time PCR was performed using the iQ5 Real-Time PCR Detection System (BioRad, Munic, Germany). Sense (s) and antisense (as) primers were used to amplify gene-specific regions: 5′-CGGAGTTGCTAAACTCAACATC-3′ (s) and 5′-TGGAGACCAGTACCGGCT-3′ (as) for ENaC-α; 5′-ATGTGGTTCCTGCTTACGCTG-3′ (s) and 5′-GTCCTGGTGGTGTTGCTGTG-3′ (as) for ENaC-β; 5′-CCAAAGCCAGCAAATAAACAAA-3′ (s) and 5′-GCGGCGGGCAATAATAGAGA-3′ (as) for ENaC-γ; 5′-TTCTTCACGCCCCTATGTCGA-3′ (s) and 5′-GCTCCAATCACAATGAACACCA-3′ (as) for CFTR; and 5′-TCATACTCAAGACTCCGTCC-3′ (s) and 5′-TACCACTTGTTTCTCCGTCC-3′ (as) for Villin. For data analysis, gene transcript expression was calculated relative to Villin expression in the same experiment.
Detection of autoantibodies by enzyme-linked immunosorbent assay. For the assessment of serum levels of colonic Ag-specific IgG and IgM autoantibodies, microtiter plates were coated overnight with 10 μg ml−1 whole Wt colonic tissue lysate and incubated with sera at a dilution of 1:50. Bound IgG or IgM antibodies were detected using horseradish peroxidase–conjugated rabbit-anti-mouse IgG or IgM antiserum (1:4000, Biozol, Eching, Germany) in conjunction with 3,3′,5,5′ tetramethylbenzidine substrate (BD Biosciences). Serum was prepared from blood obtained by cardiac puncture and stored at −80 °C. For the preparation of colonic tissue lysate, organs were homogenized in lysis buffer containing 100 mM KCl, 30 mM NaCl, 35 mM MgCl2, 100 mM Pipes, 12.5 mM EGTA, 0.5% NP-40, and a cocktail of protease inhibitors, pH 6.8.
Determination of secreted cytokines. Colon segments (transverse, distal) of 2-months-old mice were incubated in 500 μl serum-free RPMI 1640 medium containing Pen/Strep for 22 h at 37 °C and 5% CO2. Supernatants were harvested and assayed for secreted IL-6, TNF-α, IFN-γ, IL-4, and IL-13 using the Mouse Inflammation Cytometric Bead Array kit (BD Biosciences) and for IL-1β using the corresponding Flex Sets. Data were analyzed with the FCAP Array v1.0.1 software (BD Biosciences) according to the manufacturer's instructions. Cytokine concentration was indicated by the fluorescent intensity and finally normalized to colon weight. Undiluted supernatants were also assayed for secreted IL-15 using a mouse IL-15 ELISA kit (BD Biosciences). Recombinant IL-15 served as a standard and IL-15 concentrations were normalized to colonic weight.
Statistical analysis. Results are expressed as arithmetic means±standard deviation (s.d.) or standard error of the mean (s.e.m.), as indicated. Values of P<0.05 were considered statistically significant and determined either by an unpaired, two-tailed Mann–Whitney test or an unpaired, two-tailed Student's t test, as indicated.
Brandtzaeg, P. Mucosal immunity: induction, dissemination, and effector functions. Scand J Immunol 70, 505–515 (2009).
Cerf-Bensussan, N. & Gaboriau-Routhiau, V. The immune system and the gut microbiota: friends or foes? Nat Rev Immunol 10, 735–744 (2011).
Eberl, G. A new vision of immunity: homeostasis of the superorganism. Mucosal Immunol 3, 450–460 (2011).
Artis, D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 8, 411–420 (2008).
Brandtzaeg, P., Kiyono, H., Pabst, R. & Russell, M.W. Terminology: nomenclature of mucosa-associated lymphoid tissue. Mucosal Immunol 1, 31–37 (2008).
Forster, R. et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99, 23–33 (1999).
Muller, G., Hopken, U.E. & Lipp, M. The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity. Immunol Rev 195, 117–135 (2003).
Hopken, U.E., Winter, S., Achtman, A.H., Kruger, K. & Lipp, M. CCR7 regulates lymphocyte egress and recirculation through body cavities. J Leukoc Biol 87, 671–682 (2010).
Davalos-Misslitz, A.C. et al. Generalized multi-organ autoimmunity in CCR7-deficient mice. Eur J Immunol 37, 613–622 (2007).
Winter, S. et al. Manifestation of spontaneous and early autoimmune gastritis in CCR7-deficient mice. Am J Pathol 179, 754–65 (2011).
Mankertz, J. & Schulzke, J.D. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications. Curr Opin Gastroenterol 23, 379–383 (2007).
Headstrom, P.D. & Surawicz, C.M. Chronic diarrhea. Clin Gastroenterol Hepatol 3, 734–737 (2005).
Binder, H.J. Causes of chronic diarrhea. N Engl J Med 355, 236–239 (2006).
Hopken, U.E. et al. CCR7 deficiency causes ectopic lymphoid neogenesis and disturbed mucosal tissue integrity. Blood 109, 886–895 (2007).
Schmitz, H. et al. Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology 116, 301–309 (1999).
Schmitz, H. et al. Tumor necrosis factor-alpha (TNFalpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6. J Cell Sci 112 (Pt 1), 137–146 (1999).
Hoving, J.C. et al. B cells that produce immunoglobulin E mediate colitis in BALB/c mice. Gastroenterology 142, 96–108 (2012).
Eberl, M. et al. Microbial isoprenoid biosynthesis and human gammadelta T cell activation. FEBS Lett 544, 4–10 (2003).
Hofmann, A.M. & Abraham, S.N. New roles for mast cells in modulating allergic reactions and immunity against pathogens. Curr Opin Immunol 21, 679–686 (2009).
Galli, S.J., Grimbaldeston, M. & Tsai, M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 8, 478–486 (2008).
Araki, Y., Andoh, A., Fujiyama, Y. & Bamba, T. Development of dextran sulphate sodium-induced experimental colitis is suppressed in genetically mast cell-deficient Ws/Ws rats. Clin Exp Immunol 119, 264–269 (2000).
Hue, S. et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 21, 367–377 (2004).
Mention, J.J. et al. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 125, 730–745 (2003).
Barmeyer, C. et al. IL-1beta and TNFalpha regulate sodium absorption in rat distal colon. Biochem Biophys Res Commun 317, 500–507 (2004).
Barmeyer, C. et al. Mechanisms of diarrhea in the interleukin-2-deficient mouse model of colonic inflammation. Am J Physiol Gastrointest Liver Physiol 286, G244–252 (2004).
Schulzke, J.D., Andres, S., Amasheh, M., Fromm, A. & Gunzel, D. Anti-diarrheal mechanism of the traditional remedy Uzara via reduction of active chloride secretion. PLoS One 6, e18107 (2011).
Zeissig, S. et al. Altered ENaC expression leads to impaired sodium absorption in the noninflamed intestine in Crohn's disease. Gastroenterology 134, 1436–1447 (2008).
Roux, J. et al. Interleukin-1beta decreases expression of the epithelial sodium channel alpha-subunit in alveolar epithelial cells via a p38 MAPK-dependent signaling pathway. J Biol Chem 280, 18579–18589 (2005).
Autenrieth, I.B., Bucheler, N., Bohn, E., Heinze, G. & Horak, I. Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation. Gut 41, 793–800 (1997).
MacDermott, R.P. & Stenson, W.F. Alterations of the immune system in ulcerative colitis and Crohn's disease. Adv Immunol 42, 285–328 (1988).
Sartor, R.B. Pathogenetic and clinical relevance of cytokines in inflammatory bowel disease. Immunol Res 10, 465–471 (1991).
Brombacher, F. The role of interleukin-13 in infectious diseases and allergy. Bioessays 22, 646–656 (2000).
Musch, M.W. et al. T cell activation causes diarrhea by increasing intestinal permeability and inhibiting epithelial Na+/K+-ATPase. J Clin Invest 110, 1739–1747 (2002).
Suenaert, P. et al. Effects of T cell-induced colonic inflammation on epithelial barrier function. Inflamm Bowel Dis 16, 1322–1331 (2011).
Perera, L.P. Interleukin 15: its role in inflammation and immunity. Arch Immunol Ther Exp (Warsz) 48, 457–464 (2000).
Obermeier, F. et al. IL-15 protects intestinal epithelial cells. Eur J Immunol 36, 2691–2699 (2006).
Coombes, J.L., Robinson, N.J., Maloy, K.J., Uhlig, H.H. & Powrie, F. Regulatory T cells and intestinal homeostasis. Immunol Rev 204, 184–194 (2005).
Izcue, A., Coombes, J.L. & Powrie, F. Regulatory lymphocytes and intestinal inflammation. Annu Rev Immunol 27, 313–338 (2009).
Murai, M., Krause, P., Cheroutre, H. & Kronenberg, M. Regulatory T-cell stability and plasticity in mucosal and systemic immune systems. Mucosal Immunol 3, 443–449 (2011).
Garty, H. & Palmer, L.G. Epithelial sodium channels: function, structure, and regulation. Physiol Rev 77, 359–396 (1997).
Amasheh, S. et al. Cytokine-dependent transcriptional down-regulation of epithelial sodium channel in ulcerative colitis. Gastroenterology 126, 1711–1720 (2004).
Bergann, T. et al. Glucocorticoids and tumor necrosis factor-alpha synergize to induce absorption by the epithelial sodium channel in the colon. Gastroenterology 136, 933–942 (2009).
Choi, J.Y. et al. Interleukin-1beta suppresses epithelial sodium channel beta-subunit expression and ENaC-dependent fluid absorption in human middle ear epithelial cells. Eur J Pharmacol 567, 19–25 (2007).
Cafferata, E.G., Gonzalez-Guerrico, A.M., Giordano, L., Pivetta, O.H. & Santa-Coloma, T.A. Interleukin-1beta regulates CFTR expression in human intestinal T84 cells. Biochim Biophys Acta 1500, 241–248 (2000).
Andus, T. et al. Imbalance of the interleukin 1 system in colonic mucosa—association with intestinal inflammation and interleukin 1 receptor antagonist [corrected] genotype 2. Gut 41, 651–657 (1997).
Hoffman, H.M. & Wanderer, A.A. Inflammasome and IL-1beta-mediated disorders. Curr Allergy Asthma Rep 10, 229–235 (2011).
Gattorno, M. et al. Differentiating PFAPA syndrome from monogenic periodic fevers. Pediatrics 124, e721–728 (2009).
Akiho, H., Ihara, E., Motomura, Y. & Nakamura, K. Cytokine-induced alterations of gastrointestinal motility in gastrointestinal disorders. World J Gastrointest Pathophysiol 2, 72–81 (2011).
Gan, H.T. & Chen, J.D. Induction of heme oxygenase-1 improves impaired intestinal transit after burn injury. Surgery 141, 385–393 (2007).
Nakao, A. et al. Immunomodulatory effects of inhaled carbon monoxide on rat syngeneic small bowel graft motility. Gut 52, 1278–1285 (2003).
Dixon, M.F., Genta, R.M., Yardley, J.H. & Correa, P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 20, 1161–1181 (1996).
Kroesen, A.J. et al. Impairment of epithelial transport but not of barrier function in idiopathic pouchitis after ulcerative colitis. Gut 50, 821–826 (2002).
Troeger, H. et al. Effect of chronic Giardia lamblia infection on epithelial transport and barrier function in human duodenum. Gut 56, 328–335 (2007).
This work was funded by the Priority Program SFB 633 of the German Research Foundation (DFG) and the DFG grant SCHU 2389/1-1. We are grateful to K. Krüger, A. Fromm, B. Jebautzke, K. Räbel, and H. Schwede for excellent technical assistance. We are indebted to Armin Rehm for helpful suggestions and critical reading of the manuscript.
The authors declared no conflict of interest.
SUPPLEMENTARY MATERIAL is linked to the online version of the paper
About this article
Cite this article
Schumann, M., Winter, S., Wichner, K. et al. CCR7 deficiency causes diarrhea associated with altered ion transport in colonocytes in the absence of overt colitis. Mucosal Immunol 5, 377–387 (2012). https://doi.org/10.1038/mi.2012.15
This article is cited by
iNKT cells prevent obesity-induced hepatic steatosis in mice in a C-C chemokine receptor 7-dependent manner
International Journal of Obesity (2018)
Nonmuscle Myosin IIA Regulates Intestinal Epithelial Barrier in vivo and Plays a Protective Role During Experimental Colitis
Scientific Reports (2016)